NCT05482698View on ClinicalTrials.gov

The MC2-25 Cream in Subjects wITh CHronic KIdNEy Disease-aSsociated prurituS (ITCHINESS) Trial

PHASE2CompletedINTERVENTIONAL

Enrollment

111

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

February 2, 2024

Study Completion Date

February 2, 2024

Conditions

Chronic Kidney Disease-associated Pruritus

Interventions

DRUG

MC2-25 cream

Topical application

DRUG

MC2-25 vehicle

Topical application

Trial Locations (1)

Unknown

The Royal London Hospital, London

Sponsors

Lead Sponsor

MC2 Therapeutics

All Listed Sponsors

lead

MC2 Therapeutics

INDUSTRY